Ведение беременностей, наступивших после экстракорпорального оплодотворения у женщин с привычным невынашиванием, обусловленным иммунологическими нарушениями
Ведение беременностей, наступивших после экстракорпорального оплодотворения у женщин с привычным невынашиванием, обусловленным иммунологическими нарушениями
Ведение беременностей, наступивших после экстракорпорального оплодотворения у женщин с привычным невынашиванием, обусловленным иммунологическими нарушениями
1. Ghazeeri GS, Kutteh WH. Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 2001; 16 (10): 2130–5.
2. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 13–23.
3. Tomassetti C, Meuleman C, Pexsters A et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online. 2006; 13 (1): 58–64.
4. Christiansen O.B. Evidence-based investigations and treatments of recurrent pregnancy loss. Curr Opin Obstet Gynecol 2006; 18 (3): 304–12.
5. Szekeres-Bartho J, Faust Z, Varga P et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35 (4): 348–51.
6. Halbmayer WM, Feichtinger W, Kindermann C et al. Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hamostaseologie 2005; 25 (4): 391–3.
7. Heilmann L. Antithrombotic therapy in high risk pregnancy. Hematol Oncology Clin North Am 2000; 13 (5): 1133–50.
8. Matsubayashi H, Arai T, Izumi S. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76 (4): 694–9.
9. Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 29–37.
10. Stern C, Chamley L, Hale L et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70 (5): 938–44.
11. Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online 2006; 13 (1): 47–57.